News

  • The 24 year old fixing the ‘toxic’ student rental market 26 November 2021 A former Bristol student bent on fixing the 'toxic' student rental market now employs 10 people and is closing in on £500,000 of funding.
  • Blood pressure drugs could protect against type 2 diabetes 11 November 2021 BHF-funded researchers suggest lowering blood pressure should be added as a strategy for diabetes prevention.
  • Parent-collected nose swabs are as good as nurse-collected nose swabs at detecting respiratory infections in children 10 November 2021 Nose swab samples collected by parents are as good as those collected by nurses at detecting respiratory infections in children, according to a study by researchers at the University of Bristol published in the journal Microbiology Spectrum today (10 November).
  • Baby teeth may one day help identify kids at risk for mental disorders later in life 10 November 2021 Like the rings of a tree, teeth contain growth lines that may reveal clues about childhood experiences. The thickness of growth marks in primary (or “baby”) teeth may help identify children at risk for depression and other mental health disorders later in life, according to a ground-breaking investigation led by researchers at Massachusetts General Hospital (MGH) using data from a world-renowned health study in Bristol and published in JAMA Network Open.
  • Bristol student takes fifth in debut triathlon world champs 8 November 2021 A Bristol student has claimed fifth place in his debut World Triathlon Para Championships.
  • Non-invasive breathing support for COVID-19 patients isn’t linked to heightened infection risk 4 November 2021 The use of non-invasive breathing support, commonly known as CPAP or HFNO, to treat moderate to severe COVID-19 infection, isn’t linked to a heightened infection risk, as currently thought, suggest two new studies which included work led by University of Bristol researchers. The findings and a linked editorial are published today [4 November] in Thorax .
  • Lung capacity tests found to be accurate precursor of co-morbidities 2 November 2021 One of the largest studies to investigate whether Preserved Ratio Impaired Spirometry (PRISm), an understudied low lung function state, is an early predictor of co-morbidities has found it is strongly associated with an increased risk of death. The analysis, led by University of Bristol researchers and published in The Lancet Respiratory Medicine, evaluated results of lung spirometry tests in over 350,000 UK adults and followed them up over 12 years.
  • GW4 celebrates successful £7m Wellcome Trust bid for PhD programme for health professionals 28 October 2021 The GW4 Alliance is set to launch a new PhD programme for health professionals after receiving a £7m grant from the Wellcome Trust.
  • New research identifies who should be offered testing for coeliac disease 25 October 2021 Targeted testing of individuals with a range of signs and symptoms could improve diagnosis of coeliac disease, a new National Institute for Health Research (NIHR) funded study led by the University of Bristol and published in PLOS ONE has found. Signs and symptoms include family history of coeliac disease, dermatitis herpetiformis, anaemia, type 1 diabetes, osteoporosis and chronic liver disease.
  • Eliminating hepatitis C in Pakistan could yield a return-on-investment of US$9.10 billion 22 October 2021 Pakistan has one of the highest rates of hepatitis C virus (HCV) infection in the world, accounting for over ten per cent of global HCV infections. A new modelling study led by the University of Bristol, UK, suggests that achieving the World Health Organization goal of eliminating HCV as a public health problem by 2030 in Pakistan is likely to be highly cost-effective by 2030, cost-saving by 2031, and could deliver US$9.10 billion in savings to the Pakistan national economy by 2050.
  • Can portable air filters prevent respiratory infections and COVID-19 in care homes? 21 October 2021 A major new randomised controlled trial will investigate the effectiveness of air filtration systems in preventing respiratory infections (such as coughs, colds and flu) and COVID-19 among care home residents in England. The AFRI-c (Air Filters to Prevent Respiratory Infections including COVID-19 in Care Homes) study, which received funding from the National Institute for Health Research (NIHR), is led by researchers at the University of Bristol.
  • Region’s top football clubs back new #ChangeChampions domestic abuse campaign 15 October 2021 Bristol Rovers, Bath City FC and Newport’s County In The Community, three of the region’s leading football clubs and charitable organisations, are teaming up with University of Bristol researchers to back #ChangeChampions — a new domestic abuse campaign aimed at supporting men who want to change their behaviour in relationships with women.
  • New study shines a light on likely suicide among children and young people in England 14 October 2021 A new report led by University of Bristol academics has identified that 108 young people in England died under circumstances that were assessed as highly or moderately likely to be due to suicide between 2019 and 2020. The analysis, led by the University of Bristol’s National Child Mortality Database [NCMD] programme, which gathers comprehensive information on all children who die in England below the age of 18 years with the aim of identifying ways that could help reduce them in future, is published today [14 Oct].
  • Ruby Wax to headline this month’s Good Grief Festival 13 October 2021 American-British actress, comedian, writer, mental health campaigner and lecturer - Ruby Wax - will headline the Good Grief Festival, which returns later this month (Saturday 30 and Sunday 31 October).
  • Collaborative COVID-19 lockdown effort delivers major boost for vaccine innovation in Bristol 7 October 2021 Faster vaccine development could be a step closer thanks to £4 million investment to Imophoron Ltd, a Bristol University biotech start-up developing a novel, next generation rapid-response vaccine platform called ADDomer™. Imophoron will use the investment to bring ADDomer vaccines to clinical stage, initially targeting three viruses, RSV (respiratory syncytial virus), COVID-19, and mosquito-borne Chikungunya.
  • Allergies including asthma and hay fever not linked to mental health traits 6 October 2021 Allergic diseases such as asthma, atopic dermatitis and hay fever do not cause the onset of mental health conditions or vice versa, according to the findings of a new University of Bristol-led study published today (6 October) in the journal Clinical and Experimental Allergy.
  • It is safe for people to be vaccinated against COVID-19 and influenza at the same time, study shows 30 September 2021 Research has found that it is safe for people to receive a flu vaccine at the same time as a COVID-19 vaccine. Reported side effects were mainly mild to moderate, and there were no negative impacts on the immune response produced by either vaccine when both were given on the same day, in opposite arms.
  • Bristol students join prestigious health leadership programme 30 September 2021 Two medicine students from the University of Bristol have been selected to join a scholarship that aims to develop the health leaders of the future.
  • Staying on long-term antidepressants reduces risk of relapse 29 September 2021 When people stop taking antidepressants after a long period of use, just over half (56 per cent) experience a relapse within a year, compared to 39 per cent of those who stay on medication, finds a new study led by UCL and involving researchers from the universities of Bristol, Southampton, York and McMaster University in Canada.
  • Largest trial of antibiotic amoxicillin for treating chest infections in children finds little effect 28 September 2021 The largest randomised placebo-controlled trial of the antibiotic amoxicillin for treating chest infections in children - one of the most common acute illnesses treated in primary care in developed countries, has found it is little more effective at relieving symptoms than the use of no medication. The study, published in The Lancet and funded by the National Institute for Health Research (NIHR), was led by researchers from the University of Southampton and supported by centres at the Universities of Bristol, Oxford and Cardiff.

Population Health Sciences

Press releases relating to Population Health Sciences.

Translational Health Sciences

Press releases relating to Translational Health Sciences.

Years iterator
Edit this page